atrial natriuretic peptide


Also found in: Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
Related to atrial natriuretic peptide: aldosterone, atrial natriuretic factor

atrial natriuretic peptide

n.
A peptide hormone that is produced by the right atrium of the heart in response to elevated blood pressure and stimulates the excretion of sodium and water by the kidneys. Also called atrial natriuretic factor.
References in periodicals archive ?
By the late second trimester, the drop in Hb is typically by 1-2 g/dL and stabilizes thereafter in the third trimester, when there is a reduction in maternal plasma volume (due to an increase in levels of atrial natriuretic peptide).
Hori, "Atrial natriuretic peptide polarizes human dendritic cells toward a Th2-promoting phenotype through its receptor guanylyl cyclase-coupled receptor A," The Journal of Immunology, vol.
Weidmann et al., "Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure," Kidney International, vol.
Tamburrini et al., "Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients," Journal of Hypertension, vol.
BFBO at a concentration of 10 [micro]g/ml significantly potentiated the relaxation in response to cyclic GMP-elevating vasodilators such as atrial natriuretic peptide and SNP in rings without endothelium (Figs.
The secondary FITC-conjugated anti-mouse antibody (Sigma) at 1:100 dilution for anti a actinin, myosin heavy chain, and cardiac troponin T and FITC-conjugated donkey anti-rabbit antibody (Santa Cruz) for atrial natriuretic peptide with the same dilution were used.
The background for discovery of OT in the cardiovascular system was created by experiments on atrial natriuretic peptide (ANP) released into the circulation during experimental blood volume expansion (BVE).
Angiotensin II, atrial natriuretic peptide and intrarenal dopamine play a pivotal role in this interactive network.
With expiry not until March 2027, both the patents support the company's programme developing synthetic mimetics of the neuropeptide hormone atrial natriuretic peptide.
Full browser ?